Evidence map›Paper›PMID 29417048›Full record

ArticleFrontiers in surgery2018

Antibiotic Prophylaxis in Prostate Biopsies: Contemporary Practice Patterns in Germany.

Katharina Boehm, Fabian P Siegel, Laila Schneidewind, Jennifer Kranz, Philipp Spachmann, Tanja Frank, Nina Huck, Florian Imkamp, Alexandre Pelzer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Katharina BoehmUniversitätsmedizin Mainz, Klinik und Poliklinik für Urologie und Kinderurologie, Mainz, Germany.
Fabian P SiegelUniversitätsmedizin Mannheim, Klinik für Urologie, Mannheim, Germany.
Laila SchneidewindUniversitätsmedizin Greifswald, Klinik für Innere Medizin C, Hämatologie/Onkologie, Greifswald, Germany.
Jennifer KranzSt.-Antonius Hospital, Klinik für Urologie und Kinderurologie, Akademisches Lehrkrankenhaus der RWTH Aachen, Eschweiler, Germany.
Philipp SpachmannCaritas Krankenhaus St. Josef, Klinik für Urologie, Universität Regensburg, Regensburg, Germany.
Tanja FrankKlinikum Rosenheim, Klinik für Urologie und Kinderurologie, Rosenheim, Germany.
Nina HuckUniversitätsmedizin Mannheim, Klinik für Urologie, Mannheim, Germany.
Florian ImkampMedizinische Hochschule Hannover, Klinik für Urologie und urologische Onkologie, Hannover, Germany.
Alexandre PelzerDepartment of Urology, Hospital Wels-Grieskirchen, Wels, Austria.
Caritas-Krankenhaus St. Josef · DEHeidelberg University · DEJohannes Gutenberg University Mainz · DEKlinikum Wels-Grieskirchen · ATMedizinische Hochschule Hannover · DERWTH Aachen University · DEUniversitätsmedizin Greifswald · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeProstate biopsy (pbx) is the most common outpatient procedure in urology. Complications are urinary tract infections, including hospitalization and sepsis. Recommendations on antibiotic prophylaxis (apx) are scarce, and healthcare data are not available. The study addressed the following endpoints: the duration and spectrum of antimicrobial prophylaxis in transrectal and transperineal pbx in the hospital and the practice setting.

methodsA questionnaire compiled data about age, gender, board certification, and place of work. Information about the frequency of pbx, duration and type of apx, usage of disinfecting lubricant, and urine or rectal swab cultures was collected. The study refers to German urologists.

resultsOverall 478 urologists answered the questionnaire. 15.5% (74) of respondents were residents. 50.8% (243) of urologists work in a practice; the rest in a hospital. Only 4.8% do not perform pbx. Transrectal pbx are performed a median of two times a week. The majority (446, 98%) prescribe an apx, mostly fluoroquinolones (407, 89.5%). In total, 10.1% (46) of the participants use a single-shot-apx. apx has a median duration of 4 days. One-third uses a disinfecting lubricant. Urine and rectal swab cultures are analyzed by 45.5% (207) and 24.4% (111), respectively.

conclusionMost urologists prescribe an extended apx for both transrectal and transperineal pbx. Perineal pbx is still a deviation from everyday practice and not an established alternative to transrectal pbx. Urologists are aware of the increasing fluoroquinolone-resistance and are adapting with rectal swab and urine cultures. Further studies need to evaluate alternatives to 5-day apx and results should be addressed in our guidelines. This is of importance in light of the increasing resistance rates and fluoroquinolone side effects.

Indexed as

antibiotic prophylaxisantibiotic stewardshiphealthcare researchperineal biopsyprostate biopsytransrectal biopsy

Identifiers

PMID29417048
PMCPMC5787537
OpenAlexW2791383243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.